Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
Journal Title: Turkish Journal of Hematology - Year 2017, Vol 34, Issue 4
Abstract
Objective: Cancer, one of the principal causes of death, is a global social health problem. Autoantibodies developed against the organism’s self-antigens are detected in the sera of subjects with cancer. In recent years carbonic anhydrase (CA) I and II autoantibodies have been shown in some autoimmune diseases and carcinomas, but the mechanisms underlying this immune response have not yet been explained. The aim of this study was to evaluate CA I and II autoantibodies in patients with acute myeloid leukemia (AML) and to provide a novel perspective regarding the autoimmune basis of the disease. Materials and Methods: Anti-CA I and II antibody levels were investigated using ELISA in serum samples from 30 patients with AML and 30 healthy peers. Results: Anti-CA I and II antibody titers in the AML group were significantly higher compared with the control group (p=0.0001 and 0.018, respectively). A strong positive correlation was also determined between titers of anti-CA I and II antibodies (r=0.613, p=0.0001). Conclusion: Our results suggest that these autoantibodies may be involved in the pathogenesis of AML. More extensive studies are now needed to reveal the entire mechanism.
Authors and Affiliations
Ahmet Menteşe, Nergiz Erkut, Selim Demir, Serap Özer Yaman, Ayşegül Sümer, Şeniz Doğramacı, Mehmet Sönmez
Keywords
Related Articles
- EP ID EP240031
- DOI 10.4274/tjh.2016.0341
- Views 80
- Downloads 0
Health-Related Quality of Life, Depression, Anxiety, and Self-Image in Acute Lymphocytic Leukemia Survivors
Objective: With increasing survival rates in childhood acute lymphocytic leukemia (ALL), the long-term side effects of treatment have become important. Our aim was to investigate health-related quality of life, depressio...
Megadose Methylprednisolone (MDMP) for Hemangiomatosis
To the Editor, Dr. Küpeli and his colleagues[1] should be congratulated for their success in treating hemangiomatosis, which could be life threatining depending on the localization of hemangiomas, with propranolol. I pr...
Discrepancies in Lymphoma Diagnosis Over the Years: A 13-Year Experience in a Tertiary Center
Objective: In the past, accurate diagnosis of lymphoma was challenging since there were multiple competing classification systems that caused confusion and debate. After establishment of the World Health Organization lym...
The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
Objective: The purpose of this study is to investigate the relationship between the CD56 and CD117 expressions and the clinical and laboratory findings in multiple myeloma (MM) patients. Materials and Methods: Analyses...
From Bone Marrow Necrosis to Gaucher Disease; A Long Way to Run